Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
542 questions in 42 reviews · Skin
current versionsNo studies 542 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Acitretin 50 mg daily vs hydroxychloroquine 400 mg daily Relapse · people with discoid lupus erythematosus Drugs for discoid lupus erythematosus (2017) · Cochrane | no estimate extracted | NR | No studies |
Itraconazole (200 mg for 6 to 8 weeks) vs placebo Percentage of lesions cured after the end of treatment · patients with Old World cutaneous leishmaniasis Interventions for Old World cutaneous leishmaniasis (2017) · Cochrane | no estimate extracted | NR | No studies |
Itraconazole (200 mg for 6 to 8 weeks) vs placebo Speed of healing (time taken to be 'cured') · patients with Old World cutaneous leishmaniasis Interventions for Old World cutaneous leishmaniasis (2017) · Cochrane | no estimate extracted | NR | No studies |
Paromomycin ointment vs vehicle Percentage of lesions cured after the end of treatment · patients with Old World cutaneous leishmaniasis Interventions for Old World cutaneous leishmaniasis (2017) · Cochrane | no estimate extracted | NR | No studies |
Paromomycin ointment vs vehicle Speed of healing (time taken to be 'cured') · patients with Old World cutaneous leishmaniasis Interventions for Old World cutaneous leishmaniasis (2017) · Cochrane | no estimate extracted | NR | No studies |
Antibiotic prophylaxis vs no treatment/placebo Quality of life · People with recurrent erysipelas or cellulitis Interventions for the prevention of recurrent erysipelas and cellulitis (2017) · Cochrane | no estimate extracted | NR | No studies |
Terbinafine vs placebo Quality of life · patients with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Azole vs placebo Quality of life · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Griseofulvin vs azole Quality of life · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Griseofulvin vs terbinafine Recurrence rate · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Griseofulvin vs terbinafine Quality of life · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Combination terbinafine plus azole vs terbinafine monotherapy Recurrence rate · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Combination terbinafine plus azole vs terbinafine monotherapy Quality of life · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Azole vs terbinafine Quality of life · participants with confirmed toenail onychomycosis Oral antifungal medication for toenail onychomycosis (2017) · Cochrane | no estimate extracted | NR | No studies |
Moisturisers vs no treatment (no moisturiser) Change from baseline in disease severity according to participants ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Atopiclair vs vehicle Change in use of topical active treatment ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Atopiclair vs vehicle Change from baseline in health‐related quality of life ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Moisturisers vs no treatment (no moisturiser) Participant satisfaction ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Urea‐containing moisturisers vs vehicle, placebo or no moisturiser Change in use of topical active treatment ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Urea‐containing moisturisers vs vehicle, placebo or no moisturiser Change from baseline in health‐related quality of life ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Glycerin/glycerol‐containing moisturisers vs vehicle or placebo Participant satisfaction ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Glycerin/glycerol‐containing moisturisers vs vehicle or placebo Number of participants who experienced a flare ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Glycerin/glycerol‐containing moisturisers vs vehicle or placebo Change in use of topical active treatment ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Glycerin/glycerol‐containing moisturisers vs vehicle or placebo Change from baseline in health‐related quality of life ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Licochalcone‐containing moisturiser vs hydrocortisone acetate 1% cream Change from baseline in disease severity according to participants ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Licochalcone‐containing moisturiser vs hydrocortisone acetate 1% cream Change in use of active topical treatment ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Licochalcone‐containing moisturiser vs hydrocortisone acetate 1% cream Change from baseline in quality of life ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Vehicle treatment + daily moisturiser vs fluticasone propionate twice weekly + daily moisturiser Participant satisfaction ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Vehicle treatment + daily moisturiser vs fluticasone propionate twice weekly + daily moisturiser Change in use of topical active treatment ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Vehicle treatment + daily moisturiser vs fluticasone propionate twice weekly + daily moisturiser Change from baseline in quality of life ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Topical active treatment in combination with moisturiser vs topical active treatment alone Change from baseline in disease severity according to participants ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
Topical active treatment in combination with moisturiser vs topical active treatment alone Change in amount of use topical active treatment ‐ not measured · people with eczema Emollients and moisturisers for eczema (2017) · Cochrane | no estimate extracted | NR | No studies |
MAL‐PDT vs red light only Paticipant's global assessment of improvement ‐ Not measured · Moderate and severe acne vulgaris Light therapies for acne (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs non‐fractional non‐ablative laser Participant‐reported scar improvement (long‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs radiofrequency Participant‐assessed adverse events (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs radiofrequency Participant satisfaction · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs radiofrequency Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs combined chemical peeling plus needling Participant‐reported scar improvement (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs combined chemical peeling plus needling Investigator‐assessed adverse events (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs combined chemical peeling plus needling Participant satisfaction · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Fractional laser vs combined chemical peeling plus needling Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs placebo or no treatment Participant‐reported scar improvement (long‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs placebo or no treatment Participant‐reported scar improvement (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs placebo or no treatment Investigator‐assessed adverse events (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs placebo or no treatment Participant‐assessed adverse events (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs placebo or no treatment Participant satisfaction · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs placebo or no treatment Quality of life · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs combined chemical peeling plus any active intervention Participant‐reported scar improvement (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs combined chemical peeling plus any active intervention Investigator‐assessed adverse events (short‐term) · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |
Chemical peeling vs combined chemical peeling plus any active intervention Participant satisfaction · people with acne scars Interventions for acne scars (2016) · Cochrane | no estimate extracted | NR | No studies |